Patents Assigned to APT Pharmaceuticals, LLC
  • Patent number: 7183112
    Abstract: A diversity of inflammatory diseases can be treated via local delivery to the patient of a composition containing a therapeutically effective amount of an anti-malarial agent. In a preferred embodiment of the method of the invention, a pulmonary inflammatory condition, such as asthma, is treated by inhalation of an aerosolized anti-malarial agent, such as hydroxychloroquine.
    Type: Grant
    Filed: April 18, 2003
    Date of Patent: February 27, 2007
    Assignee: APT Pharmaceuticals, LLC
    Inventor: B. Lauren Charous
  • Publication number: 20030224008
    Abstract: A diversity of inflammatory diseases can be treated via local delivery to the patient of a composition containing a therapeutically effective amount of an anti-malarial agent. In a preferred embodiment of the method of the invention, a pulmonary inflammatory condition, such as asthma, is treated by inhalation of an aerosolized anti-malarial agent, such as hydroxychloroquine.
    Type: Application
    Filed: April 18, 2003
    Publication date: December 4, 2003
    Applicant: APT Pharmaceuticals, LLC
    Inventor: B. Lauren Charous
  • Patent number: 6572858
    Abstract: A diversity of inflammatory diseases can be treated via local delivery to the patient of a composition containing a therapeutically effective amount of an anti-malarial agent. In a preferred embodiment of the method of the invention, a pulmonary inflammatory condition, such as asthma, is treated by inhalation of an aerosolized anti-malarial agent, such as hydroxychloroquine.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: June 3, 2003
    Assignee: APT Pharmaceuticals, LLC
    Inventor: B. Lauren Charous